IRONWOOD PHARMACEUTICALS INC (IRWD) Stock Analyst Ratings

NASDAQ:IRWD • US46333X1081

4.78 USD
0 (0%)
At close: Feb 18, 2026
4.78 USD
0 (0%)
After Hours: 2/18/2026, 5:39:20 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to IRWD. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 4.95. This target is 3.49% above the current price.
  • IRWD was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about IRWD.
  • In the last month the buy percentage rose by 29 points. So the trust of analysts is improving.
  • IRWD was analyzed by 10 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
IRWD Historical Analyst RatingsIRWD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 4.780.715.464.958.40 - -85.21% 14.16% 3.49% 75.73%

Related screens

Find peers 30% below price target
IRWD Current Analyst RatingIRWD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2026-01-05 Citizens Upgrade Market Perform -> Market Outperform
2026-01-05 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2025-11-11 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2025-04-15 Wells Fargo Downgrade Overweight -> Equal-Weight
2025-04-15 Jefferies Downgrade Buy -> Hold
2025-04-14 Leerink Partners Maintains Market Perform -> Market Perform
2025-01-30 JMP Securities Maintains Market Outperform -> Market Outperform
2025-01-22 Craig-Hallum Maintains Buy -> Buy
2024-09-09 Leerink Partners Initiate Market Perform
2024-08-09 Wells Fargo Maintains Overweight -> Overweight
2024-08-09 Craig-Hallum Maintains Buy -> Buy
2024-05-10 Craig-Hallum Maintains Buy -> Buy
2024-03-01 Wells Fargo Maintains Overweight -> Overweight
2024-02-16 Piper Sandler Maintains Overweight -> Overweight
2024-01-17 Craig-Hallum Initiate Buy
2023-12-14 Wells Fargo Initiate Overweight
2023-09-28 JMP Securities Initiate Market Outperform
2023-05-23 Piper Sandler Maintains Overweight -> Overweight
2022-08-16 Wells Fargo Maintains Equal-Weight
2022-04-22 Piper Sandler Initiate Overweight
2021-10-12 Morgan Stanley Maintains Equal-Weight
2021-07-16 Morgan Stanley Maintains Equal-Weight
2021-02-22 Morgan Stanley Maintains Equal-Weight
2021-02-19 Morgan Stanley Maintains Equal-Weight

IRONWOOD PHARMACEUTICALS INC / IRWD FAQ

What is the price target for IRWD stock?

10 analysts have analysed IRWD and the average price target is 4.95 USD. This implies a price increase of 3.49% is expected in the next year compared to the current price of 4.78.


How do analysts rate IRONWOOD PHARMACEUTICALS INC (IRWD)?

The consensus rating for IRONWOOD PHARMACEUTICALS INC (IRWD) is 78 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed IRONWOOD PHARMACEUTICALS INC (IRWD)?

The number of analysts covering IRONWOOD PHARMACEUTICALS INC (IRWD) is 10.